New Delhi: Emami-backed nutrition startup TruNativ has secured $30 million in a Series B funding round led by healthcare-focused investment firm OrbiMed. The round included a combination of fresh capital and secondary transactions involving some of the company’s early investors.
According to media reports, the company said it will use the new funds to strengthen its distribution across direct-to-consumer (D2C), quick commerce, modern trade, pharmacy, and other retail channels. It also plans to expand its B2B2C ingredients business.
Founded in 2019 by mother-son duo Pranav Malhotra and Mamta Malhotra, TruNativ offers products across multiple nutrition segments, including sugar substitutes, protein, gut health, beauty wellness, and performance nutrition.
According to the company, it has established a strong position in the sugar replacement segment on quick-commerce platforms and currently leads the dietary fibre and sweeteners categories on Amazon India.
TruNativ’s portfolio includes Everyday Sweet in the sugar substitution category, Everyday Protein and Pro Blend Whey for protein nutrition, Everyday Fiber for gut health, Advanced Collagen for beauty wellness, and products aimed at performance nutrition.
OrbiMed manages around $20 billion in assets across public equities, private equity, venture capital, and royalty strategies, investing globally in healthcare sectors including biotechnology, pharmaceuticals, medical devices, and healthcare services.
